Depressive symptoms in cerebral amyloid angiopathy track cortical damage, not just distress

Design

cross-sectional two-site case-control study with mediation analysis

Population

85 adults with probable CAA (mean age 73.5) and 83 controls (mean age 68.8)

Primary outcome

cognitive performance by domain and GDS-15 depressive symptom score

Effect

odds of possible depression 15.71 (95% CI 4.26-80.05); depression mediated 11% of the effect on episodic memory

Eighty-five people with probable cerebral amyloid angiopathy and 83 controls recruited from memory and stroke prevention clinics at two sites were assessed across episodic memory, executive function and processing speed, with depressive symptoms measured on the 15-item Geriatric Depression Scale. CAA status was associated with worse performance in every cognitive domain, and with markedly higher depression scores: odds of possible depression 15.71 (95% CI 4.26 to 80.05) and GDS-15 scores 2.71 times higher (95% CI 2.10 to 3.51).

Mediation analysis found depressive symptoms accounted for 11% of the CAA effect on episodic memory and 9% on executive function, but only 2% on processing speed, which did not reach significance. The pattern is informative: depression explains part of the deficit in the domains most sensitive to effort and engagement, and almost none of the deficit in raw speed.

The imaging associations are what lift this above a correlation. Within the 81 CAA participants with imaging, higher depression scores went with lower mean cortical thickness (count ratio 1.33 per standard deviation decrease, 95% CI 1.09 to 1.62) and with cortical superficial siderosis (2.04, 95% CI 1.35 to 3.09). That points towards mood symptoms arising partly from the cortical disease itself rather than purely as a reaction to a frightening diagnosis - which matters, because the two call for different responses.

• Screen for depression in CAA rather than attributing low mood to the diagnosis or to age.
• Reassess cognition after treating depression before concluding the deficit is fixed.
• Note cortical superficial siderosis on imaging as a flag for mood assessment, not only haemorrhage risk.
• Distinguish apathy from depression: the domains affected here were effort-dependent.
• Be cautious with drugs affecting bleeding risk when treating depression in a population defined by haemorrhage-prone vessels.

Why it matters

It raises the possibility that some of the cognitive impairment attributed to CAA is treatable mood disturbance being scored as dementia.

Don't overread it

This is cross-sectional and observational: it cannot show that depression causes the cognitive deficit, or that treating it improves cognition.

The statistics, in plain English

The odds ratio of 15.71 has a confidence interval from 4.26 to 80.05 - enormously wide, because the numbers in each cell are small. The direction is beyond doubt; the magnitude is not, and quoting '15 times' as a precise figure would overstate what 168 people can show. The mediation percentages, 9 to 11%, are modest: depression explains a real but small slice of the cognitive difference, and treating it will not restore the rest.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.